Those brilliant minds at Tel Aviv University have discovered that Prozac, that archetypal drug for depression, enhances the effect of a common chemotherapeutic agent, doxorubicin, by a factor of ten.

Dr. Dan Peer of the Department of Cell Research and Immunology claims that Prozac works by blocking resistance to the anti-cancer drug. Specifically, it prevents the drug from leaving the interior of the cancer cell and poisoning the healthy, non-cancerous cells that surround it.

Unfortunately for the researchers, but fortunately for everyone else, is the fact that this therapy can’t be commercialized – any doctor can prescribe Prozac.

Dr. Peer and his colleagues will be conducting further research into Prozac’s anti-cancer capacities, to see if it enhances the effects of other cancer treatment modalities.

Soon, your cancer treatment may well just come packaged with a dose of mental quietude in a pill.